Pathology News
admin

About admin@pathologynews.com

This author has not yet filled in any details.
So far admin@pathologynews.com has created 1089 blog entries.

May 2025

New in Concentriq AP: Streamlined Consults, Personalized Worklists, Expanded DICOM Support, and More

2025-05-01T15:12:17+00:00

Here at Proscia, we believe the key to achieving productivity and confidence in digital pathology lies in delivering an intelligent and intuitive platform where pathologists can work naturally from day one. That’s why this release builds on last quarter’s updates to improve the day-to-day experience of pathology teams in modern anatomic pathology labs.

New in Concentriq AP: Streamlined Consults, Personalized Worklists, Expanded DICOM Support, and More2025-05-01T15:12:17+00:00

The Power of Partnership: How GE Healthcare and Tribun Health Are Advancing Oncology

2025-05-01T10:35:01+00:00

In medicine, as in leadership, clarity, efficiency, and decision-making are key. Oncology is no exception. Yet, too often, critical clinical data is fragmented—genomics in one system, pathology in another, radiology elsewhere. This siloed approach serves no one, least of all the patient.

The Power of Partnership: How GE Healthcare and Tribun Health Are Advancing Oncology2025-05-01T10:35:01+00:00

Case of the Month | May 2025 | Large Granular Lymphocyte Lymphoma

2025-07-28T09:08:13+00:00

A 12-year-old spayed female Beagle was presented to a veterinary clinic with a history of a golf ball-sized mass on the neck. A fine-needle aspiration (FNA) was performed, and the sample was submitted to NationWide Laboratories for evaluation.

Case of the Month | May 2025 | Large Granular Lymphocyte Lymphoma2025-07-28T09:08:13+00:00

April 2025

Low and Ultralow HER2 Expression in Breast Cancer is Now Detectable by Indica Labs’ Breast IHC AI

2025-04-30T13:44:09+00:00

Indica Labs, the leading provider of AI-powered digital pathology solutions, announces today an update to their Breast IHC AI suite, an image analysis tool used for the quantification of HER2, ER, PR, and Ki67 within AI-identified, tumor regions, of breast cancer tissue specimens. The HER2 algorithm will now include functionality for the detection of low and ultralow HER2 expression in breast cancer.

Low and Ultralow HER2 Expression in Breast Cancer is Now Detectable by Indica Labs’ Breast IHC AI2025-04-30T13:44:09+00:00

U.S. Payers and CGP

2025-06-03T13:11:14+00:00

TruSight Oncology Comprehensive (TSO Comprehensive) is the first U.S. FDA-approved, distributable comprehensive genomic profiling (CGP) kit with pan-cancer companion diagnostic (CDx) claims, across solid malignant neoplasms, conveys a distinct clinical utility that payers appreciate.

U.S. Payers and CGP2025-06-03T13:11:14+00:00

Imagene Recognized Among Top 25 Healthcare AI Companies of 2025

2025-04-30T09:00:27+00:00

The Healthcare Technology Report has announced its prestigious list of The Top 25 Healthcare AI Companies of 2025, recognizing the transformative impact of artificial intelligence across the healthcare landscape. Among the awardees is Imagene, a standout innovator in AI-powered precision oncology.

Imagene Recognized Among Top 25 Healthcare AI Companies of 20252025-04-30T09:00:27+00:00

Roche Granted FDA Breakthrough Device Designation for First AI-driven Companion Diagnostic for Non-small Cell Lung Cancer

2025-04-30T08:44:08+00:00

Roche announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation for the VENTANA® TROP2 (EPR20043) RxDx Device. This is the first Breakthrough Device Designation to be granted for a computational pathology companion diagnostic (CDx) device.

Roche Granted FDA Breakthrough Device Designation for First AI-driven Companion Diagnostic for Non-small Cell Lung Cancer2025-04-30T08:44:08+00:00

HistoWiz and PathologyOutlines.com Partner to Streamline Digital Slide Integration for Pathology Publications via PathologyMap™ Platform

2025-04-28T14:45:14+00:00

HistoWiz, Inc., a global leader in histopathology services and digital pathology innovation, has formed a strategic partnership with PathologyOutlines.com, the world’s most visited pathology education platform.

HistoWiz and PathologyOutlines.com Partner to Streamline Digital Slide Integration for Pathology Publications via PathologyMap™ Platform2025-04-28T14:45:14+00:00

Single-Nucleus RNA-Sequencing Sheds Light on the Spatial Landscape of Glioblastoma’s Subventricular Zone

2025-05-15T08:38:44+00:00

by Christos Evangelou, MSc, PhD – Medical Writer and Editor Glioblastoma (GBM) is one of the most challenging cancers to treat, with poor survival outcomes and high recurrence rates. A new study from the University of New Mexico, in collaboration with the University of Mississippi Medical Center and the Medical University of South Carolina, mapped the complex [...]

Single-Nucleus RNA-Sequencing Sheds Light on the Spatial Landscape of Glioblastoma’s Subventricular Zone2025-05-15T08:38:44+00:00

Leica Biosystems Unveils Novel Fluorescent Digital Pathology Scanner, the Aperio FL Digital System, at AACR Annual Meeting

2025-04-26T11:00:58+00:00

Leica Biosystems is pleased to announce the debut of its latest digital pathology innovation, the Aperio FL digital system, at the American Association of Cancer Researchers (AACR) Annual Meeting in Chicago, Illinois, from April 25-30, 2025.

Leica Biosystems Unveils Novel Fluorescent Digital Pathology Scanner, the Aperio FL Digital System, at AACR Annual Meeting2025-04-26T11:00:58+00:00
Go to Top